Clinical Trials Browser

Melanoma × STA 9090 × Clear all

NCT01551693 2017-04-12

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Terminated

3 enrolled 7 charts

Melanoma, Neoplasm Metastasis